International Trade & IP Committee

The IGBA International Trade & IP Committee aims to develop a more competitive business environment for the generic and biosimilar medicines industries around the globe. It also promotes the implementation of balanced, well-functioning and transparent intellectual property systems in all jurisdictions.

Its purpose is to foster the spread of generic and biosimilar medicines worldwide increasing their market penetration through the dismantling of barriers to trade, regulatory harmonization, reduction of costs linked to administrative burdens and red tape, and a fair balance between IPR protection and public health needs. The ultimate objective aims to bring competition to markets at the earliest appropriate opportunity which  provides patients with timely access to cost-saving generic and biosimilar medicines. This objective also supports the sustainability and future growth of investments made by the industry in new product development, manufacturing and the litigation that is generally required to bring new generic pharmaceuticals and biosimilar medicines to domestic markets.

To accomplish this, the generic and biosimilar medicines industries require particular attention and a high level of collaboration and coordination among the different regional Associations and their Member companies. The IGBA International Trade & IP Committee, by virtue of its global perspective, will develop coordinated strategies for the achievements of such goals.


IGBA open letter to the Director General of WIPO regarding Pat-INFORMED

Trilateral Letter on NAFTA from the Generic and Biosimilar Medicines Industries

IGBA Files Recommendations for USTR 2016 Special 301 Review – February 5, 2016

Statement by the International Generic and Biosimilar Medicines Association on the Signing of the Trans-Pacific Partnership Agreement – February 4, 2016

Report: Fostering International Trade in Generic and Biosimilar Medicines – September 2015

IGPA Recommendations for Office of the United States Trade Representative 2015 Special 301 Review

IGPA Statement on the Trans-Pacific Partnership (TPP) Negotiations

Joint EGA & GPHA response to the EU-US high level working group on jobs and growth on regulatory issues

IGPA Strategic Interest Statement for the TTIP negotiations

Contact Info


Rue des Pierres-du-Niton 17
1207 Geneva

Telephone: +32 (0)2 5346607
This email address is being protected from spambots. You need JavaScript enabled to view it.  
This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site